NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) —

Eyenovia, Inc.

(NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, announced that the Company will release financial results for the first quarter ended March 31, 2022 on Thursday, May 12, 2022, after the markets close. Following the release, Eyenovia management will host a conference call to review the financial and operating results.

The conference call is scheduled to begin at 4:30pm ET on Thursday, May 12, 2022. Participants should dial 1-877-207-9876 (domestic) or 1-212-231-2932 (international) with the conference code 22018217. A live webcast of the conference call will also be available on the investor relations page of the Company’s corporate website at

www.eyenovia.com

.

After the live webcast, the event will be archived on Eyenovia’s website for one year.

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit

www.eyenovia.com

.

The Eyenovia Corporate Information slide deck may be found at

ir.eyenovia.com/events-and-presentations

.

Eyenovia Contact:


Eyenovia, Inc.

John Gandolfo

Chief Financial Officer



[email protected]

Eyenovia Investor Contact:


Eric Ribner

LifeSci Advisors, LLC



[email protected]



(646) 751-4363

Eyenovia Media Contact:


Eyenovia, Inc.

Norbert Lowe

Vice President, Commercial Operations



[email protected]